farrerol has been researched along with Cancer of Stomach in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, S; Han, L; Li, Q; Liang, T; Liu, E; Wang, X | 1 |
| Li, J; Li, Q; Liang, T; Liu, E; Shi, S; Wang, X; Wu, B | 1 |
2 other study(ies) available for farrerol and Cancer of Stomach
| Article | Year |
|---|---|
Apoptosis induced by farrerol in human gastric cancer SGC-7901 cells through the mitochondrial-mediated pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspase 9; Cell Proliferation; Chromones; Humans; Membrane Potential, Mitochondrial; Mitochondria; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured | 2015 |
Sustained ERK activation-mediated proliferation inhibition of farrerol on human gastric carcinoma cell line by G0/G1-phase cell-cycle arrest.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Chromones; G1 Phase; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Resting Phase, Cell Cycle; Stomach Neoplasms; Tumor Cells, Cultured | 2016 |